Search
for
Sort by
Research
720-750 / 1000+ results
research Co-editors' Messages
The document's conclusion cannot be summarized because the content is not accessible or understandable.
research Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
GT20029 helps regrow hair in men with hair loss and is well-tolerated.
research Surgeon of the month
The document's conclusion cannot be determined because the content is not available.
research Finasteride for treatment of refractory hemospermia: prospective placebo-controlled study
research Surgeon of the Month: Robert Reese, DO
The document cannot be processed to provide a conclusion.
research Maintaining arc consistency using adaptive domain ordering
EREG therapy may help treat hair loss by promoting hair growth.
research Formulation and evaluation of self-nanoemulsifying drug delivery system for improved oral delivery of exemestane hydrochloride
The new drug delivery system improves exemestane's absorption and effectiveness.
research 44047 Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.
research Cyberspace Chat: Scalp biopsies: to refer or not to refer?
The conclusion cannot be provided because the document is not accessible.
research Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration
The document's conclusion cannot be provided because the document is not available for analysis.
research 5 alpha-reductase inhibition by a new synthetic steroid (PM-9) in cultures of Penicillium crustosum.
PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.
research Message from the ISHRS 2016 World Congress Program Chair
The document's content couldn't be processed to provide a conclusion.
research Message from the ISHRS 2016 World Congress Program Chair
The document's content couldn't be processed to provide a conclusion.
research A 2019 Guide to Currently Accepted FUE and Implanter Terminology
research Notes from the Editor Emeritus, 2002–04
I'm sorry, but I can't provide a summary without content from the document.
research Scalp Reduction: Mirror, Mirror on the Wall
The document's conclusion cannot be provided because the document is not accessible or understandable.
research Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
The cream effectively and safely reduces facial hair in women.
research Assessing tolerability and physiological responses to 17α-estradiol administration in male rhesus macaques
research Deposition of 18-MEA onto Damaged Hair to Form a Persistent Hydrophobicity
18-MEA and SPDA can restore damaged hair's smoothness and reduce frizz.
research Barcelona Update
The document's conclusion cannot be summarized because the content is not accessible.
research Diffuse hair loss
The document's conclusion cannot be summarized because it is not readable or understandable.
research 17β-Estradiol Increases APE1/Ref-1 Secretion in Vascular Endothelial Cells and Ovariectomized Mice: Involvement of Calcium-Dependent Exosome Pathway
17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.
research Pearls of Wisdom
The document's conclusion cannot be provided because the document cannot be parsed.
research Pioneer’s Page
The document could not be understood or processed.
research BG01 Confirming small nuclear ribonucleoprotein polypeptide E as a cause of nonsyndromic hypotrichosis
The protein called small nuclear ribonucleoprotein polypeptide E is identified as a cause of a type of hair loss without other symptoms.
research 861 EGFR/MEK inhibitor therapy induces partial hair follicle immune privilege collapse in vivo and ex vivo
research Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa™), a Novel Treatment for Excessive Facial Hair
Eflornithine HCl 13.9% cream is safe for skin use with mild, temporary irritation.
research Skin and diabetes and endocrinology
The document's conclusion cannot be provided because the content is not available.
research My Clinical Experience with Needle and Laser SMP Devices
The document's conclusion cannot be provided because the content is not available.